Page 28 - Group Website News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ROCKLAND, Mass., Feb. 3, 2021 /PRNewswire/ -- EMD Serono, the healthcare business sector of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced that the US Food and Drug Administration (FDA) has approved TEPMETKO ® (tepotinib) following Priority Review for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition ( MET) exon 14 skipping alterations. This indication is approved under accelerated approval based on overall response rate and duration of response. Continued...

(PRNewsfoto/EMD Serono) ROCKLAND, Mass. and NEW YORK, Jan. 25, 2021 /PRNewswire/ -- EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has approved BAVENCIO ® (avelumab) as monotherapy for the first-line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (UC) who are progression-free following platinum-based chemotherapy. "Avelumab is the only immunotherapy to demonstrate a significant improvement in overall survival in th...

Not intended for UK-based media Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced an update on the Phase III [email protected] Lung 037 study and the extensive [email protected] clinical trial program for the potential first-in-class investigational bifunctional immunotherapy bintrafusp alfa, in difficult-to-treat cancers, including biliary tract cancer (BTC) and cervical cancer. The comprehensive [email protected] program is designed to assess the impact of bintrafusp alfa across distinct cancers and settings where TGF-β is thought to play a driv...

Merck KGaA, Darmstadt, Germany, at CES 2021: Materials and Solutions for Advancing Digital Living Merck KGaA, Darmstadt, Germany shares its vision for Advancing Digital Living at CES 2021. As the company behind the companies, Merck KGaA, Darmstadt, Germany's innovative materials and solutions enable the digital transformation accelerated by the global pandemic DARMSTADT, Germany - December 14, 2020 - (Newswire.com) Merck KGaA, Darmstadt, Germany, a leading science and technology company, will present its latest technology advancements for the electronics industry at the Consu...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada and Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending approval of BAVENCIO ® as monotherapy for the first-line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma who … – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada and Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicin...